Intravenously delivered neural stem cells migrate into ischemic brain, differentiate and improve functional recovery after transient ischemic stroke in adult rats

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 3, 2015, Pages 2928-2936

  Cheng, Yi ^a,c   Zhang, Jinjing ^a   Deng, Liancheng ^a   Johnson, Noah R ^b   Yu, Xichong ^a   Zhang, Ning ^a   Lou, Tianzheng ^a   Zhang, Yi ^a   Wei, Xiaojie ^a   Chen, Zaifeng ^a   He, Songbin ^a   Li, Xiaokun ^a   Xiao, Jian ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c Department of Pharmacy Longyou People's Hospital   (China)

Author keywords

Cell transplantation; Intravenous administration; Ischemic stroke; Neural stem cells

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CELL LINE; CELL MOTION; CONVALESCENCE; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; ISCHEMIC ATTACK, TRANSIENT; MALE; MOUSE; NEURAL STEM CELL; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; STEM CELL TRANSPLANTATION; TRANSPLANTATION; XENOGRAFT;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; HETEROGRAFTS; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; NEURAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION;

EID: 84933034776     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL and Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8: 355-369.
2. Grossman AW and Broderick JP. Advances and challenges in treatment and prevention of ischemic stroke. Ann Neurol 2013; 74: 363-372.
3. Thwaites JW, Reebye V, Mintz P, Levicar N and Habib N. Cellular replacement and regenerative medicine therapies in ischemic stroke. Regen Med 2012; 7: 387-395.
4. Modo, M, Rezaie P, Heuschling P, Patel S, Male DK and Hodges H. Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response. Brain Res 2002; 958: 70-82.
5. Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, Masel J, Yenari MA, Weissman IL, Uchida N, Palmer T and Steinberg GK. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 2004; 101: 11839-11844.
6. Wurmser AE, Nakashima K, Summers RG, Toni N, D'Amour KA, Lie DC and Gage FH. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 2004; 430: 350-356.
7. Wu P, Tarasenko YI. Gu Y, Huang LY, Coggeshall RE and Yu Y. Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat Neurosci 2002; 5: 1271-1278.
8. Snyder EY, Deitcher DL, Walsh C, Arnold-Aldea S, Hartwieg EA and Cepko CL. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 1992; 68: 33-51.
9. Yang M, Stull ND, Berk MA, Snyder EY and Iacovitti L. Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopamine-lesioned rat. Exp Neurol 2002; 177: 50-60.
10. Yang CR and Yu RK. Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease. J Neurosci Res 2009; 87: 26-33.
11. Riess P, Zhang C, Saatman KE, Laurer HL, Longhi LG, Raghupathi R, Lenzlinger PM, Lifshitz J, Boockvar J, Neugebauer E, Snyder EY and McIntosh TK. Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 2002; 51: 1043-1052; discussion 1052-1044.
12. Lee IS, Jung K, Kim M and Park KI. Neural stem cells: properties and therapeutic potentials for hypoxic-ischemic brain injury in newborn infants. Pediatr Int 2010; 52: 855-865.
13. Snyder EY, Yoon C, Flax JD and Macklis JD. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc Natl Acad Sci U S A 1997; 94: 11663-11668.
14. Yan J, Welsh AM, Bora SH, Snyder EY and Koliatsos VE. Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord. J Comp Neurol 2004; 480: 101-114.
15. Bliss TM, Andres RH and Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010; 37: 275-283.
16. Longa EZ, Weinstein PR, Carlson S and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
17. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M and Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32: 1005-1011.
18. Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T, Sanberg CD, Sanberg PR and Willing AE. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004; 35: 2390-2395.
19. Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, Nakashima S, Yoshimura S and Iwama T. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 2011; 13: 675-685.
20. Shen CC, Lin CH, Yang YC, Chiao MT, Cheng WY and Ko JL. Intravenous implanted neural stem cells migrate to injury site, reduce infarct volume, and improve behavior after cerebral ischemia. Curr Neurovasc Res 2010; 7: 167-179.
21. Kranz A, Wagner DC, Kamprad M, Scholz M, Schmidt UR, Nitzsche F, Aberman Z, Emmrich F, Riegelsberger UM and Boltze J. Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Res 2010; 1315: 128-136.
22. Wang Y, Deng Y and Zhou GQ. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 2008; 1195: 104-112.
23. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY and Khoury SJ. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 2004; 101: 18117-18122.
24. Allport JR, Shinde Patil VR and Weissleder R. Murine neuronal progenitor cells are preferentially recruited to tumor vasculature via alpha4-integrin and SDF-1alpha-dependent mechanisms. Cancer Biol Ther 2004; 3: 838-844.
25. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC and Chopp M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 2003; 73: 778-786.
26. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, Lu M, Zhu Z and Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003; 92: 692-699.
27. Chu K, Kim M, Park KI, Jeong SW, Park HK, Jung KH, Lee ST, Kang L, Lee K, Park DK, Kim SU and Roh JK. Human neural stem cells improve sensorimotor deficits in the adult ratbrain with experimental focal ischemia. Brain Res 2004; 1016: 145-153.
28. Chu K, Kim M, Jeong SW, Kim SU and Yoon BW. Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 2003; 343: 129-133.